Sanofi
SARCLISA
Manufacturer:
Sanofi
Name:
SARCLISA
HCPCS Code Descriptor:
Injection, isatuximab-irfc, 10 mg
Category:
J Code
HCPCS:
J9227
NDC(s):
00024-0654-01, 00024-0656-01
Primary Type:
Oncology
Generic Status:
Single-Source
Route of Administration:
Intravenous
About:
SARCLISA is an Oncology drug manufactured by Sanofi and administered via the Intravenous route of administration. The J Code: J9227 is aligned to the drug SARCLISA.
Access Pricing and More By Registering
HCPCS Added Date:
10/1/20
HCPCS Effective Date:
10/1/20
HCPCS Short Description:
Inj. isatuximab-irfc 10 mg
Billing and Coding Guide:
https://www.sarclisahcp.com/assets/pdfs/SARCLISA_Billing_and_Coding_Guide_MAT-US-2102121-v2.pdf
Patient Assistance:
https://www.sanoficareassist.com/
